Peisheng Xu
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$1.2MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $1.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 12, 2024 | NIH | STTR Phase I Develop a novel strategy to deliver N-acetylcysteine for AD treatment | $499K | AcePre, LLC |
| Sep 30, 2022 | NIH | STTR Phase I The development of a multifunctional nanoenzyme for AD treatment | $300K | AcePre, LLC with UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA |
| 2021 | NIH | STTR Phase I A novel polymer-metal nanocomplex for ovarian cancer treatment | $393K | AcePre, LLC with UNIVERSITY OF SOUTH CAROLINA |
Peer ranks
Federal funding#1,607
Awards as PI#822
Patents#273
Companies
- AcePre, LLCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.